FDA Removes Vaccine Risk Warning From Elanco's Zenrelia Label Following Peer-Reviewed Data; Global Vet Experience Reinforces Efficacy

Author: Benzinga Newsdesk | September 23, 2025 06:30am

• FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified live virus vaccines from the labeling"i
• Further evaluation of supplemental scientific data drove this FDA update; data now peer-reviewed and published
• Real-world success and experiences from dermatologists and general practice veterinarians around the U.S. and the world further demonstrate Zenrelia's efficacy

INDIANAPOLIS, Sept. 23, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced important updates to the U.S. Zenrelia label, following the Food and Drug Administration (FDA) review of supplemental scientific data.   

Posted In: ELAN